139 related articles for article (PubMed ID: 8212145)
1. Diminution of an acute cyclosporin-induced cholestasis by tauroursodeoxycholate in the rat.
Queneau PE; Bertault-Perès P; Mesdjian E; Durand A; Montet JC
Transplantation; 1993 Sep; 56(3):530-4. PubMed ID: 8212145
[TBL] [Abstract][Full Text] [Related]
2. Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.
Baumgartner U; Schölmerich J; Sellinger M; Reinhardt M; Ruf G; Farthmann EH
Dig Dis Sci; 1996 Feb; 41(2):250-5. PubMed ID: 8601366
[TBL] [Abstract][Full Text] [Related]
3. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats.
Tsukahara K; Kanai S; Ohta M; Kitani K
Liver; 1993 Oct; 13(5):262-9. PubMed ID: 8259039
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
[TBL] [Abstract][Full Text] [Related]
5. Difference in the effects of ursodeoxycholate and its taurine conjugate on the biliary excretion of sulfobromophthalein in the rat.
Kanai S; Kitani K; Sato Y
J Hepatol; 1990 Mar; 10(2):174-9. PubMed ID: 2332588
[TBL] [Abstract][Full Text] [Related]
6. Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat.
Queneau PE; Bertault-Peres P; Guitaoui M; Mesdjian E; Durand A; Montet JC
Dig Dis Sci; 1994 Jul; 39(7):1581-5. PubMed ID: 8026273
[TBL] [Abstract][Full Text] [Related]
7. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes.
Bouchard G; Yousef IM; Tuchweber B
Liver; 1993 Aug; 13(4):193-202. PubMed ID: 8377596
[TBL] [Abstract][Full Text] [Related]
8. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
[TBL] [Abstract][Full Text] [Related]
9. Cholestatic effects of cyclosporine in the rat.
Chan FK; Shaffer EA
Transplantation; 1997 Jun; 63(11):1574-8. PubMed ID: 9197348
[TBL] [Abstract][Full Text] [Related]
10. Bile secretory characteristics of beta-muricholate and its taurine conjugate are similar to those of ursodeoxycholate in the rat.
Kanai S; Kitani K; Sato Y
Life Sci; 1991; 48(10):949-57. PubMed ID: 2000026
[TBL] [Abstract][Full Text] [Related]
11. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic index of taurocholate or tauroursodeoxycholate in experimental drug-induced cholestasis.
Utili R; Adinolfi LE; Tripodi MF
Ital J Gastroenterol; 1995; 27(6):332-4. PubMed ID: 8563000
[TBL] [Abstract][Full Text] [Related]
13. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate.
Sano N; Takikawa H; Yamanaka M
J Hepatol; 1993 Feb; 17(2):241-6. PubMed ID: 8445238
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients.
Caroli-Bosc FX; Iliadis A; Salmon L; Macheras P; Montet AM; Bourgeon A; Garraffo R; Delmont JP; Montet JC
Fundam Clin Pharmacol; 2000; 14(6):601-9. PubMed ID: 11206711
[TBL] [Abstract][Full Text] [Related]
15. Taurohyocholate, taurocholate, and tauroursodeoxycholate but not tauroursocholate and taurodehydrocholate counteract effects of taurolithocholate in rat liver.
Schölmerich J; Kitamura S; Baumgartner U; Miyai K; Gerok W
Res Exp Med (Berl); 1990; 190(2):121-9. PubMed ID: 2349395
[TBL] [Abstract][Full Text] [Related]
16. Effects of bile salt infusion on chlorpromazine-induced cholestasis in the isolated perfused rat liver.
Utili R; Tripodi MF; Abernathy CO; Zimmerman HJ; Gillespie J
Proc Soc Exp Biol Med; 1992 Jan; 199(1):49-53. PubMed ID: 1728036
[TBL] [Abstract][Full Text] [Related]
17. Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocyte couplets.
Thibault N; Maurice M; Maratrat M; Cordier A; Feldmann G; Ballet F
J Hepatol; 1993 Nov; 19(3):367-76. PubMed ID: 8151096
[TBL] [Abstract][Full Text] [Related]
18. Lithocholate-3-O-glucuronide-induced cholestasis. A study with congenital hyperbilirubinemic rats and effects of ursodeoxycholate conjugates.
Takikawa H; Minagawa K; Sano N; Yamanaka M
Dig Dis Sci; 1993 Aug; 38(8):1543-8. PubMed ID: 8344113
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholate alleviates alcoholic fatty liver damage in rats.
Oliva L; Beaugé F; Choquart D; Montet AM; Guitaoui M; Montet JC
Alcohol Clin Exp Res; 1998 Oct; 22(7):1538-43. PubMed ID: 9802540
[TBL] [Abstract][Full Text] [Related]
20. Effects of curcumin on cyclosporine-induced cholestasis and hypercholesterolemia and on cyclosporine metabolism in the rat.
Deters M; Klabunde T; Meyer H; Resch K; Kaever V
Planta Med; 2003 Apr; 69(4):337-43. PubMed ID: 12709901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]